Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2003-12-07 Regulatory Filings
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
New Patents Awarded 1 page ?Kb
Regulatory Filings Classification · 95% confidence The document is a short announcement dated 8 December 2003 addressed to the Australian Stock Exchange. It reports the awarding of two new patents to Genetic Technologies Limited in Ireland. The content focuses on intellectual property updates and does not contain financial data, regulatory certifications, or detailed financial reports. It is not a report itself but an announcement of a corporate event related to patents. Given the nature and length of the document, it does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2003-12-07 English
Results of Meeting 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a letter addressed to the Australian Stock Exchange announcing the results of resolutions passed at the Annual General Meeting (AGM) held on 28 November 2003. It details the number of proxy votes for, against, abstaining, and discretionary for each resolution. The document references the AGM, the resolutions passed, and proxy voting results, which are typical contents of a Declaration of Voting Results & Voting Rights Announcements filing. The document length is 3026 characters, which is relatively short and focused on voting results rather than the full AGM materials or presentations. Therefore, it is not an AGM Information presentation but specifically a declaration of voting results. Hence, the correct classification is DVA (Declaration of Voting Results & Voting Rights Announcements).
2003-11-30 English
Chairman's AGM Address to Shareholders 8 pages ?Kb
AGM Information Classification · 95% confidence The document is a detailed presentation by the Executive Chairman to the Annual General Meeting (AGM) of Genetic Technologies Limited. It includes an overview of the company's activities, achievements, and strategic direction, which is typical content for AGM presentations. The text explicitly mentions it is a presentation to the AGM and focuses on business updates rather than financial statements or regulatory filings. The length is substantial (15,000 characters), consistent with a full AGM presentation rather than a brief announcement or certification. Therefore, the document fits the category of AGM Information (AGM-R).
2003-11-27 English
Invited to join international Gene Testing Network 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 27 November 2003, addressed to the Australian Stock Exchange Limited. It announces that Genetic Technologies Limited (GTG) has joined the international GENDIA genetic testing network. The content is a corporate update about a strategic partnership and recognition in the field of genetic testing. There are no financial statements, no regulatory certifications, no voting results, no management or board changes, no earnings data, and no detailed report or presentation. The document is relatively short (2263 characters) and serves as a news announcement to the market rather than a formal report or filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and miscellaneous filings that do not fit other specific categories.
2003-11-26 English
AgGenomics Starts Generating Meaningful Results 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a company announcement addressed to the Australian Stock Exchange, dated 26 November 2003. It provides an update on the progress and business activities of AgGenomics Pty Limited, a joint venture involving Genetic Technologies Limited. The content focuses on operational and financial progress, including revenue figures and new business proposals, but does not contain detailed financial statements or comprehensive financial analysis. The document is relatively short (2434 characters) and serves as a market update rather than a full financial report or regulatory filing. It does not fit the criteria for Annual Report, Interim Report, Earnings Release, or other detailed financial filings. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement informing the market about business progress and financial performance without constituting a formal financial report or other specific filing type.
2003-11-25 English
Law Suits against Nuvelo & Covance now settled 2 pages ?Kb
Legal Proceedings Report Classification · 95% confidence The document is a letter dated 17 November 2003 addressed to the Australian Stock Exchange Company Announcements Office. It reports on the settlement of two out of three lawsuits filed by Genetic Technologies Limited against US biotechnology companies. The content focuses on legal proceedings and settlement outcomes, with no financial data, earnings, or report attachments. The document is an update on legal matters involving the company, which fits the category of Legal Proceedings Report.
2003-11-16 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.